Systemic immune-inflammation index as a promising predictor of mortality in patients with acute coronary syndrome: a real-world study

被引:23
作者
Su, Gaofan [1 ,2 ]
Zhang, Ying [1 ,2 ]
Xiao, Ruyi [3 ]
Zhang, Tingting [2 ,4 ]
Gong, Binbin [2 ,4 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 2, Dept Blood Transfus, Wenzhou, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hematopathol, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 2, Dept Clin Lab, Wenzhou, Zhejiang, Peoples R China
关键词
Acute coronary syndrome; systemic immune-inflammation index; Multiparameter Intelligent Monitoring in Intensive Care; mortality; prognosis; high-risk patient; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; CANCER;
D O I
10.1177/03000605211016274
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective Prognostic indicators in acute coronary syndrome (ACS) would aid in decision-making and identifying high-risk patients. The systemic immune-inflammation index (SII) has good prognostic value in many diseases; however, its use has not been reported for ACS. We aimed to determine the associations between the SII and outcomes in patients with ACS, with adjustment for confounders. Methods In this retrospective cohort study, we used the MIMIC-III (Multiparameter Intelligent Monitoring in Intensive Care) database and the eICU Collaborative Research Database. The primary outcome was 30-day mortality. Cox regression analysis was performed to determine the relationship between the SII and patient outcomes, and we conducted subgroup analysis and smooth curve fitting. Results We identified 4699 patients with ACS: 1741 women and 2949 men, mean age 82.8 +/- 29.7 years, and mean SII 72.58 +/- 12.9. For 30-day all-cause mortality, the unadjusted hazard ratio (HR) (95% confidence interval [CI]) of SII 88.8 were 1.25 (1.04, 1.50) and 1.38 (1.15, 1.65), respectively. With SII >88.8, this association remained significant after adjustment for numerous potential confounders: HR 1.27 (1.06, 1.52). A similar relationship was observed for 90-day and 1-year all-cause mortality. Conclusions SII is a promising prognostic indicator for unselected patients with ACS. This finding needs to be confirmed in prospective studies.
引用
收藏
页数:11
相关论文
共 26 条
[11]   Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone [J].
Lolli, Cristian ;
Caffo, Orazio ;
Scarpi, Emanuela ;
Aieta, Michele ;
Conteduca, Vincenza ;
Maines, Francesca ;
Bianchi, Emanuela ;
Massari, Francesco ;
Veccia, Antonello ;
Chiuri, Vincenzo E. ;
Facchini, Gaetano ;
De Giorgi, Ugo .
FRONTIERS IN PHARMACOLOGY, 2016, 7
[12]   Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer [J].
Lu, Yao ;
Xin, Dao ;
Wang, Feng .
ONCOTARGETS AND THERAPY, 2019, 12 :7791-7799
[13]   Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma [J].
Mirili, Cem ;
Paydas, Semra ;
Kapukaya, Tuba Korkmaz ;
Yilmaz, Ali .
BIOMARKERS IN MEDICINE, 2019, 13 (18) :1565-1575
[14]  
Molinaro Roberto, 2016, Methodist Debakey Cardiovasc J, V12, P169
[15]   Identifying Increased Risk of Readmission and In-hospital Mortality Using Hospital Administrative Data The AHRQ Elixhauser Comorbidity Index [J].
Moore, Brian J. ;
White, Susan ;
Washington, Raynard ;
Coenen, Natalia ;
Elixhauser, Anne .
MEDICAL CARE, 2017, 55 (07) :698-705
[16]  
Nahler G., 2009, ICD 9 CODE, V28, P88
[17]   The eICU Collaborative Research Database, a freely available multi-center database for critical care research [J].
Pollard, Tom J. ;
Johnson, Alistair E. W. ;
Raffa, Jesse D. ;
Celi, Leo A. ;
Mark, Roger G. ;
Badawi, Omar .
SCIENTIFIC DATA, 2018, 5
[18]   Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease [J].
Ridker, P. M. ;
Everett, B. M. ;
Thuren, T. ;
MacFadyen, J. G. ;
Chang, W. H. ;
Ballantyne, C. ;
Fonseca, F. ;
Nicolau, J. ;
Koenig, W. ;
Anker, S. D. ;
Kastelein, J. J. P. ;
Cornel, J. H. ;
Pais, P. ;
Pella, D. ;
Genest, J. ;
Cifkova, R. ;
Lorenzatti, A. ;
Forster, T. ;
Kobalava, Z. ;
Vida-Simiti, L. ;
Flather, M. ;
Shimokawa, H. ;
Ogawa, H. ;
Dellborg, M. ;
Rossi, P. R. F. ;
Troquay, R. P. T. ;
Libby, P. ;
Glynn, R. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (12) :1119-1131
[19]   Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors [J].
Shoji, Fumihiro ;
Takeoka, Hiroaki ;
Kozuma, Yuka ;
Toyokawa, Gouji ;
Yamazaki, Koji ;
Ichiki, Masao ;
Takeo, Sadanori .
LUNG CANCER, 2019, 136 :45-51
[20]   Endothelial Dysfunction and Low-Grade Inflammation Are Associated With Greater Arterial Stiffness Over a 6-Year Period [J].
van Bussel, Bas C. ;
Schouten, Fleur ;
Henry, Ronald M. ;
Schalkwijk, Casper G. ;
de Boer, Michiel R. ;
Ferreira, Isabel ;
Smulders, Yvo M. ;
Twisk, Jos W. ;
Stehouwer, Coen D. .
HYPERTENSION, 2011, 58 (04) :588-U144